TGR5, not only a metabolic regulator

Frontiers in Physiology

Volumn 7, Issue DEC, 2016, Pages

  Guo, Cong ^a   Chen, Wei Dong ^b,c   Wang, Yan Dong ^a  

^a BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY   (China)

^b HENAN UNIVERSITY   (China)

^c INNER MONGOLIA MEDICAL UNIVERSITY   (China)

Author keywords

Bile acids; Gpbar1; GPCR; Receptor; TGR5

Indexed keywords

4 BENZOFURANYLOXYNICOTINAMIDE DERIVATIVE; 6A ETHYL 23 METHYL CHOLIC ACID; CHOLIC ACID DERIVATIVE; CYCLIC AMP; G PROTEIN COUPLED BILE ACID RECEPTOR GPBAR1; G PROTEIN COUPLED RECEPTOR; GLUCAGON LIKE PEPTIDE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INT 777; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NICOTINAMIDE DERIVATIVE; PROTEIN KINASE B; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE 1 PHOSPHATE RECEPTOR 2; STAT3 PROTEIN; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

BILE ACID HOMEOSTASIS; CHRONIC INFLAMMATION; DISEASE COURSE; DISEASE EXACERBATION; DYSLIPIDEMIA; ENERGY HOMEOSTASIS; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HOMEOSTASIS; HUMAN; HYPERTENSION; LIVER REGENERATION; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; STOMACH CANCER;

EID: 85009350750     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2016.00646     Document Type: Review

References (88)

1. Agarwal, S., Patil, A., Aware, U., Deshmukh, P., Darji, B., Sasane, S., et al. (2016). Discovery of a potent and orally efficacious TGR5 receptor agonist. ACS Med. Chem. Lett. 7, 51-55. doi: 10.1021/acsmedchemlett.5b00323
2. Akira, S., Nishio, Y., Inoue, M., Wang, X. J., Wei, S., Matsusaka, T., et al. (1994). Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell 77, 63-71. doi: 10.1016/0092-8674(94)90235-6
3. Alejandro, E. U., Gregg, B., Blandino-Rosano, M., Cras-Meneur, C., and Bernal-Mizrachi, E. (2015). Natural history of beta-cell adaptation and failure in type 2 diabetes. Mol. Aspects Med. 42, 19-41. doi: 10.1016/j.mam.2014.12.002
4. Breckler, M., Berthouze, M., Laurent, A. C., Crozatier, B., Morel, E., and Lezoualc'h, F. (2011). Rap-linked cAMP signaling Epac proteins: compartmentation, functioning and disease implications. Cell. Signal. 23, 1257-1266. doi: 10.1016/j.cellsig.2011.03.007
5. Broeders, E. P., Nascimento, E. B., Havekes, B., Brans, B., Roumans, K. H., Tailleux, A., et al. (2015). The bile acid chenodeoxycholic acid increases human brown adipose tissue activity. Cell Metab. 22, 418-426. doi: 10.1016/j.cmet.2015.07.002
6. Chen, W. D., Wang, Y. D., Zhang, L., Shiah, S., Wang, M., Yang, F., et al. (2010). Farnesoid X receptor alleviates age-related proliferation defects in regenerating mouse livers by activating forkhead box m1b transcription. Hepatology 51, 953-962. doi: 10.1002/hep.23390
7. Chen, X., Lou, G., Meng, Z., and Huang, W. (2011). TGR5: a novel target for weight maintenance and glucose metabolism. Exp. Diabetes Res. 2011:853501. doi: 10.1155/2011/853501
8. Chen, X., Xu, H., Ding, L., Lou, G., Liu, Y., Yao, Y., et al. (2015). Identification of miR-26a as a target gene of bile acid receptor GPBAR-1/TGR5. PLoS ONE 10:e0131294. doi: 10.1371/journal.pone.0131294
9. Cheng, P., Alberts, I., and Li, X. (2013). The role of ERK1/2 in the regulation of proliferation and differentiation of astrocytes in developing brain. Int. J. Dev. Neurosci. 31, 783-789. doi: 10.1016/j.ijdevneu.2013.09.008
10. Coussens, L. M., and Werb, Z. (2002). Inflammation and cancer. Nature 420, 860-867. doi: 10.1038/nature01322
11. Covarrubias, A. J., Aksoylar, H. I., and Horng, T. (2015). Control of macrophage metabolism and activation by mTOR and Akt signaling. Semin. Immunol. 27, 286-296. doi: 10.1016/j.smim.2015.08.001
12. Cvijic, M. E., Sum, C. S., Alt, A., and Zhang, L. (2015). GPCR profiling: from hits to leads and from genotype to phenotype. Drug Discov. Today Technol. 18, 30-37. doi: 10.1016/j.ddtec.2015.10.005
13. DiDonato, J. A., Mercurio, F., and Karin, M. (2012). NF-κB and the link between inflammation and cancer. Immunol. Rev. 246, 379-400. doi: 10.1111/j.1600-065X.2012.01099.x
14. Donepudi, A. C., Boehme, S., Li, F., and Chiang, J. Y. (2016). G-protein-coupled bile acid receptor plays a key role in bile acid metabolism and fasting-induced hepatic steatosis in mice. Hepatology. doi: 10.1002/hep.28707. [Epub ahead of print].
15. Faes, S., and Dormond, O. (2015). PI3K and AKT: unfaithful partners in cancer. Int. J. Mol. Sci. 16, 21138-21152. doi: 10.3390/ijms160921138
16. Fan, M., Wang, X., Xu, G., Yan, Q., and Huang, W. (2015). Bile acid signaling and liver regeneration. Biochim. Biophys. Acta 1849, 196-200. doi: 10.1016/j.bbagrm.2014.05.021
17. Foord, S. M., Bonner, T. I., Neubig, R. R., Rosser, E. M., Pin, J. P., Davenport, A. P., et al. (2005). International union of pharmacology. XLVI. G protein-coupled receptor list. Pharmacol. Rev. 57, 279-288. doi: 10.1124/pr.57.2.5
18. Gloerich, M., and Bos, J. L. (2010). Epac: defining a new mechanism for cAMP action. Annu. Rev. Pharmacol. Toxicol. 50, 355-375. doi: 10.1146/annurev.pharmtox.010909.105714
19. Goedecke, J. H., and Micklesfield, L. K. (2014). The effect of exercise on obesity, body fat distribution and risk for type 2 diabetes. Med. Sport Sci. 60, 82-93. doi: 10.1159/000357338
20. Guo, C., Qi, H., Yu, Y., Zhang, Q., Su, J., Yu, D., et al. (2015a). The G-protein-coupled bile acid receptor Gpbar1 (TGR5) inhibits gastric inflammation through antagonizing NF-κB signaling pathway. Front. Pharmacol. 6:287. doi: 10.3389/fphar.2015.00287
21. Guo, C., Su, J., Li, Z., Xiao, R., Wen, J., Li, Y., et al. (2015b). The G-protein-coupled bile acid receptor Gpbar1 (TGR5) suppresses gastric cancer cell proliferation and migration through antagonizing STAT3 signaling pathway. Oncotarget 6, 34402-34413. doi: 10.18632/oncotarget.5353
22. Han, L. Y., Fan, Y. C., Mu, N. N., Gao, S., Li, F., Ji, X. F., et al. (2014). Aberrant DNA methylation of G-protein-coupled bile acid receptor Gpbar1 (TGR5) is a potential biomarker for hepatitis B Virus associated hepatocellular carcinoma. Int. J. Med. Sci. 11, 164-171. doi: 10.7150/ijms.6745
23. Hong, J., Behar, J., Wands, J., Resnick, M., Wang, L. J., DeLellis, R. A., et al. (2010). Role of a novel bile acid receptor TGR5 in the development of oesophageal adenocarcinoma. Gut 59, 170-180. doi: 10.1136/gut.2009.188375
24. Horiba, T., Katsukawa, M., Mita, M., and Sato, R. (2015). Dietary obacunone supplementation stimulates muscle hypertrophy, and suppresses hyperglycemia and obesity through the TGR5 and PPARgamma pathway. Biochem. Biophys. Res. Commun. 463, 846-852. doi: 10.1016/j.bbrc.2015.06.022
25. Johnston, C. A., Moreno, J. P., and Foreyt, J. P. (2014). Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. Curr. Atheroscler. Rep. 16, 457. doi: 10.1007/s11883-014-0457-6
26. Jourdainne, V., Péan, N., Doignon, I., Humbert, L., Rainteau, D., and Tordjmann, T. (2015). The bile acid receptor TGR5 and liver regeneration. Dig. Dis. 33, 319-326. doi: 10.1159/000371668
27. Kane, A., Deenick, E. K., Ma, C. S., Cook, M. C., Uzel, G., and Tangye, S. G. (2014). STAT3 is a central regulator of lymphocyte differentiation and function. Curr. Opin. Immunol. 28, 49-57. doi: 10.1016/j.coi.2014.01.015
28. Katsuma, S., Hirasawa, A., and Tsujimoto, G. (2005). Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochem. Biophys. Res. Commun. 329, 386-390. doi: 10.1016/j.bbrc.2005.01.139
29. Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., et al. (2003). A G protein-coupled receptor responsive to bile acids. J. Biol. Chem. 278, 9435-9440. doi: 10.1074/jbc. M209706200
30. Keitel, V., Donner, M., Winandy, S., Kubitz, R., and Häussinger, D. (2008). Expression and function of the bile acid receptor TGR5 in Kupffer cells. Biochem. Biophys. Res. Commun. 372, 78-84. doi: 10.1016/j.bbrc.2008.04.171
31. Keitel, V., Reinehr, R., Gatsios, P., Rupprecht, C., Gorg, B., Selbach, O., et al. (2007). The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells. Hepatology 45, 695-704. doi: 10.1002/hep.21458
32. Kida, T., Tsubosaka, Y., Hori, M., Ozaki, H., and Murata, T. (2013). Bile acid receptor TGR5 agonism induces NO production and reduces monocyte adhesion in vascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 33, 1663-1669. doi: 10.1161/ATVBAHA.113.301565
33. Kumar, D. P., Asgharpour, A., Mirshahi, F., Park, S. H., Liu, S., Imai, Y., et al. (2016). Activation of transmembrane bile acid receptor TGR5 modulates pancreatic islet alpha cells to promote glucose homeostasis. J. Biol. Chem. 291, 6626-6640. doi: 10.1074/jbc. M115.699504
34. Kumar, D. P., Rajagopal, S., Mahavadi, S., Mirshahi, F., Grider, J. R., Murthy, K. S., et al. (2012). Activation of transmembrane bile acid receptor TGR5 stimulates insulin secretion in pancreatic beta cells. Biochem. Biophys. Res. Commun. 427, 600-605. doi: 10.1016/j.bbrc.2012.09.104
35. Kwong, E., Li, Y., Hylemon, P. B., and Zhou, H. (2015). Bile acids and sphingosine-1-phosphate receptor 2 in hepatic lipid metabolism. Acta Pharmaceut. Sin. B 5, 151-157. doi: 10.1016/j.apsb.2014.12.009
36. Levy, D. E., and Lee, C. K. (2002). What does Stat3 do? J. Clin. Invest. 109, 1143-1148. doi: 10.1172/JCI15650
37. Lieu, T., Jayaweera, G., Zhao, P., Poole, D. P., Jensen, D., Grace, M., et al. (2014). The bile acid receptor TGR5 activates the TRPA1 channel to induce itch in mice. Gastroenterology 147, 1417-1428. doi: 10.1053/j.gastro.2014.08.042
38. Lin, X., Zhao, Y., Song, W. M., and Zhang, B. (2015). Molecular classification and prediction in gastric cancer. Comput. Struct. Biotechnol. J. 13, 448-458. doi: 10.1016/j.csbj.2015.08.001
39. Maki, K. C., and Phillips, A. K. (2015). Dietary substitutions for refined carbohydrate that show promise for reducing risk of type 2 diabetes in men and women. J. Nutr. 145, 159S-163S. doi: 10.3945/jn.114.195149
40. Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., et al. (1999). Identification of a nuclear receptor for bile acids. Science 284, 1362-1365. doi: 10.1126/science.284.5418.1362
41. Maruyama, T., Miyamoto, Y., Nakamura, T., Tamai, Y., Okada, H., Sugiyama, E., et al. (2002). Identification of membrane-type receptor for bile acids (M-BAR). Biochem. Biophys. Res. Commun. 298, 714-719. doi: 10.1016/S0006-291X(02)02550-0
42. Masyuk, A. I., Huang, B. Q., Radtke, B. N., Gajdos, G. B., Splinter, P. L., Masyuk, T. V., et al. (2013). Ciliary subcellular localization of TGR5 determines the cholangiocyte functional response to bile acid signaling. Am. J. Physiol. Gastrointest. Liver Physiol. 304, G1013-G1024. doi: 10.1152/ajpgi.00383.2012
43. McMillin, M., Frampton, G., Tobin, R., Dusio, G., Smith, J., Shin, H., et al. (2015). TGR5 signaling reduces neuroinflammation during hepatic encephalopathy. J. Neurochem. 135, 565-576. doi: 10.1111/jnc.13243
44. Meng, Z., Liu, N., Fu, X., Wang, X., Wang, Y. D., Chen, W. D., et al. (2011). Insufficient bile acid signaling impairs liver repair in CYP27(-/-) mice. J. Hepatol. 55, 885-895. doi: 10.1016/j.jhep.2010.12.037
45. Mobraten, K., Haugbro, T., Karlstrom, E., Kleiveland, C. R., and Lea, T. (2015). Activation of the bile acid receptor TGR5 enhances LPS-induced inflammatory responses in a human monocytic cell line. J. Recept. Signal Transduct. Res. 35, 402-409. doi: 10.3109/10799893.2014.986744
46. Nalliah, C. J., Sanders, P., Kottkamp, H., and Kalman, J. M. (2016). The role of obesity in atrial fibrillation. Eur. Heart J. 37, 1565-1572. doi: 10.1093/eurheartj/ehv486
47. Papademetrio, D. L., Lompardia, S. L., Simunovich, T., Costantino, S., Mihalez, C. Y., Cavaliere, V., et al. (2016). Inhibition of survival pathways MAPK and NF-kB triggers apoptosis in pancreatic ductal adenocarcinoma cells via suppression of autophagy. Target. Oncol. 11, 183-195. doi: 10.1007/s11523-015-0388-3
48. Pascoli, V., Cahill, E., Bellivier, F., Caboche, J., and Vanhoutte, P. (2014). Extracellular signal-regulated protein kinases 1 and 2 activation by addictive drugs: a signal toward pathological adaptation. Biol. Psychiatry 76, 917-926. doi: 10.1016/j.biopsych.2014.04.005
49. Péan, N., Doignon, I., Garcin, I., Besnard, A., Julien, B., Liu, B., et al. (2013). The receptor TGR5 protects the liver from bile acid overload during liver regeneration in mice. Hepatology 58, 1451-1460. doi: 10.1002/hep.26463
50. Pellicciari, R., Gioiello, A., Macchiarulo, A., Thomas, C., Rosatelli, E., Natalini, B., et al. (2009). Discovery of 6a-ethyl-23(S)-methylcholic acid (S-EMCA, INT-777) as a potent and selective agonist for the TGR5 receptor, a novel target for diabesity. J. Med. Chem. 52, 7958-7961. doi: 10.1021/jm901390p
51. Pellicciari, R., Sato, H., Gioiello, A., Costantino, G., Macchiarulo, A., Sadeghpour, B. M., et al. (2007). Nongenomic actions of bile acids. Synthesis and preliminary characterization of 23-and 6,23-alkyl-substituted bile acid derivatives as selective modulators for the G-protein coupled receptor TGR5. J. Med. Chem. 50, 4265-4268. doi: 10.1021/jm070633p
52. Perino, A., Pols, T. W., Nomura, M., Stein, S., Pellicciari, R., and Schoonjans, K. (2014). TGR5 reduces macrophage migration through mTOR-induced C/EBPß differential translation. J. Clin. Invest. 124, 5424-5436. doi: 10.1172/JCI76289
53. Pierre, J. F., Martinez, K. B., Ye, H., Nadimpalli, A., Morton, T. C., Yang, J., et al. (2016). Activation of bile acid signaling improves metabolic phenotypes in high-fat diet-induced obese mice. Am. J. Physiol. Gastrointest. Liver Physiol. 311, G286-G304. doi: 10.1152/ajpgi.00202.2016
54. Poli, V., and Camporeale, A. (2015). STAT3-mediated metabolic reprograming in cellular transformation and implications for drug resistance. Front. Oncol. 5:121. doi: 10.3389/fonc.2015.00121
55. Pols, T. W., Nomura, M., Harach, T., Lo Sasso, G., Oosterveer, M. H., Thomas, C., et al. (2011). TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading. Cell Metab. 14, 747-757. doi: 10.1016/j.cmet.2011.11.006
56. Rajagopal, S., Kumar, D. P., Mahavadi, S., Bhattacharya, S., Zhou, R., Corvera, C. U., et al. (2013). Activation of G protein-coupled bile acid receptor, TGR5, induces smooth muscle relaxation via both Epac- and PKA-mediated inhibition of RhoA/Rho kinase pathway. Am. J. Physiol. Gastrointest. Liver Physiol. 304, G527-G535. doi: 10.1152/ajpgi.00388.2012
57. Raufman, J. P., Cheng, K., Saxena, N., Chahdi, A., Belo, A., Khurana, S., et al. (2011). Muscarinic receptor agonists stimulate matrix metalloproteinase 1-dependent invasion of human colon cancer cells. Biochem. Biophys. Res. Commun. 415, 319-324. doi: 10.1016/j.bbrc.2011.10.052
58. Raufman, J. P., Cheng, K., and Zimniak, P. (2003). Activation of muscarinic receptor signaling by bile acids: physiological and medical implications. Dig. Dis. Sci. 48, 1431-1444. doi: 10.1023/A:1024733500950
59. Reich, M., Deutschmann, K., Sommerfeld, A., Klindt, C., Kluge, S., Kubitz, R., et al. (2016). TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro. Gut 65, 487-501. doi: 10.1136/gutjnl-2015-309458
60. Rohrer, D. K., and Kobilka, B. K. (1998). G protein-coupled receptors: functional and mechanistic insights through altered gene expression. Physiol. Rev. 78, 35-52.
61. Sansone, P., Storci, G., Tavolari, S., Guarnieri, T., Giovannini, C., Taffurelli, M., et al. (2007). IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J. Clin. Invest. 117, 3988-4002. doi: 10.1172/JCI32533
62. Sarbassov, D. D., Guertin, D. A., Ali, S. M., and Sabatini, D. M. (2005). Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098-1101. doi: 10.1126/science.1106148
63. Sarode, G. S., Sarode, S. C., Patil, A., Anand, R., Patil, S. G., Rao, R. S., et al. (2015). Inflammation and oral cancer: an update review on targeted therapies. J. Contemp. Dent. Pract. 16, 595-602. doi: 10.5005/jp-journals-10024-1727
64. Sasaki, T., and Kuniyasu, H. (2014). Significance of AKT in gastric cancer (Review). Int. J. Oncol. 45, 2187-2192. doi: 10.3892/ijo.2014.2678
65. Sato, H., Genet, C., Strehle, A., Thomas, C., Lobstein, A., Wagner, A., et al. (2007). Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaea. Biochem. Biophys. Res. Commun. 362, 793-798. doi: 10.1016/j.bbrc.2007.06.130
66. Shacter, E., and Weitzman, S. A. (2002). Chronic inflammation and cancer. Oncology 16, 217-226, 229; discussion 230-232.
67. Sonne, D. P., Hansen, M., and Knop, F. K. (2014). Bile acid sequestrants in type 2 diabetes: potential effects on GLP1 secretion. Eur. J. Endocrinol. 171, R47-R65. doi: 10.1530/EJE-14-0154
68. Sun, S. C., Chang, J. H., and Jin, J. (2013). Regulation of nuclear factor-κB in autoimmunity. Trends Immunol. 34, 282-289. doi: 10.1016/j.it.2013.01.004
69. Teng, Y., Ross, J. L., and Cowell, J. K. (2014). The involvement of JAK-STAT3 in cell motility, invasion, and metastasis. Jak-Stat 3:e28086. doi: 10.4161/jkst.28086
70. Tiwari, A., and Maiti, P. (2009). TGR5: an emerging bile acid G-protein-coupled receptor target for the potential treatment of metabolic disorders. Drug Discov. Today 14, 523-530. doi: 10.1016/j.drudis.2009.02.005
71. Verstrepen, L., and Beyaert, R. (2014). Receptor proximal kinases in NF-κB signaling as potential therapeutic targets in cancer and inflammation. Biochem. Pharmacol. 92, 519-529. doi: 10.1016/j.bcp.2014.10.017
72. Wang, X. X., Edelstein, M. H., Gafter, U., Qiu, L., Luo, Y., Dobrinskikh, E., et al. (2016). G protein-coupled bile acid receptor TGR5 activation inhibits kidney disease in obesity and diabetes. J. Am. Soc. Nephrol. 27, 1362-1378. doi: 10.1681/ASN.2014121271
73. Wang, Y. D., Chen, W. D., and Huang, W. (2008a). FXR, a target for different diseases. Histol. Histopathol. 23, 621-627.
74. Wang, Y. D., Chen, W. D., Moore, D. D., and Huang, W. (2008b). FXR: a metabolic regulator and cell protector. Cell Res. 18, 1087-1095. doi: 10.1038/cr.2008.289
75. Wang, Y. D., Chen, W. D., Wang, M., Yu, D., Forman, B. M., and Huang, W. (2008c). Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory response. Hepatology 48, 1632-1643. doi: 10.1002/hep.22519
76. Wang, Y. D., Chen, W. D., Yu, D., Forman, B. M., and Huang, W. (2011). The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factorκ light-chain enhancer of activated B cells (NF-κB) in mice. Hepatology 54, 1421-1432. doi: 10.1002/hep.24525
77. Watanabe, M., Houten, S. M., Mataki, C., Christoffolete, M. A., Kim, B. W., Sato, H., et al. (2006). Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439, 484-489. doi: 10.1038/nature04330
78. Yamanaka, Y., Nakajima, K., Fukada, T., Hibi, M., and Hirano, T. (1996). Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for Stat3 activation. EMBO J. 15, 1557-1565.
79. Yang, H., Zhou, H., Zhuang, L., Wang, X., and Lv, L. (2016). GPBAR1/TGR5 Attenuates Liver Ischemia/Reperfusion Injury via the Inhibition of TLR4 Signaling in Mice. Liver Transplant. doi: 10.1002/lt.24628. [Epub ahead of print].
80. Yin, W., Cheepala, S., Roberts, J. N., Syson-Chan, K., DiGiovanni, J., and Clifford, J. L. (2006). Active Stat3 is required for survival of human squamous cell carcinoma cells in serum-free conditions. Mol. Cancer 5:15. doi: 10.1186/1476-4598-5-15
81. Yoneno, K., Hisamatsu, T., Shimamura, K., Kamada, N., Ichikawa, R., Kitazume, M. T., et al. (2013). TGR5 signalling inhibits the production of pro-inflammatory cytokines by in vitro differentiated inflammatory and intestinal macrophages in Crohn's disease. Immunology 139, 19-29. doi: 10.1111/imm.12045
82. Yoshimura, A., Naka, T., and Kubo, M. (2007). SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol. 7, 454-465. doi: 10.1038/nri2093
83. Zambad, S. P., Tuli, D., Mathur, A., Ghalsasi, S. A., Chaudhary, A. R., Deshpande, S., et al. (2013). TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity. Diabetes Metab. Syndr. Obes. 7, 1-14. doi: 10.2147/DMSO.S50209
84. Zarrinpar, A., and Loomba, R. (2012). Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-alcoholic fatty liver disease. Aliment. Pharmacol. Ther. 36, 909-921. doi: 10.1111/apt.12084
85. Zheng, C., Zhou, W., Wang, T., You, P., Zhao, Y., Yang, Y., et al. (2015). A novel TGR5 activator WB403 promotes GLP-1 secretion and preserves pancreatic ß-cells in type 2 diabetic mice. PLoS ONE 10:e0134051. doi: 10.1371/journal.pone.0134051
86. Zhou, H., and Hylemon, P. B. (2014). Bile acids are nutrient signaling hormones. Steroids 86, 62-68. doi: 10.1016/j.steroids.2014.04.016
87. Zhu, J., Ning, M., Guo, C., Zhang, L., Pan, G., Leng, Y., et al. (2013). Design, synthesis and biological evaluation of a novel class of potent TGR5 agonists based on a 4-phenyl pyridine scaffold. Eur. J. Med. Chem. 69, 55-68. doi: 10.1016/j.ejmech.2013.07.050
88. Zou, Q., Duan, H., Ning, M., Liu, J., Feng, Y., Zhang, L., et al. (2014). 4-Benzofuranyloxynicotinamide derivatives are novel potent and orally available TGR5 agonists. Eur. J. Med. Chem. 82, 1-15. doi: 10.1016/j.ejmech.2014.05.031